Publication: Cell & Gene Therapy Review
Certara’s Fran Brown provides pivotal insights into the challenges poised to shape the cell and gene therapy landscape in 2025—particularly emphasizing commercial viability hurdles. The discussion revolves around innovative strategies to overcome these roadblocks, empowering the industry to advance breakthrough therapies while ensuring patient access remains at the forefront.
Published: February 3, 2025
Learn more about Cell and Gene Therapy Services
Certara is your trusted partner in advancing cell and gene therapy programs. With unmatched expertise in drug development, innovative modeling technologies, and a proven track record of success, we help you navigate the complexities of this emerging field. Let’s work together to bring life-changing therapies to patients.
